Every Form 4 that Marsh & McLennan Companies, Inc. (MMC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MMC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MMC filings page.
Marsh & McLennan Companies President and CEO John Q. Doyle reported an option exercise and related share sale. He exercised options to acquire 16,656 shares of Common Stock at $73.195 per share, then sold 16,656 shares at $161.71 per share in an open‑market transaction.
The filing notes that the sale was effected under a pre‑arranged Rule 10b5‑1 trading plan, meaning it was scheduled in advance. After these transactions, Doyle continues to hold over 100,000 shares of Marsh & McLennan stock directly.
Marsh & McLennan Companies director Morton O. Schapiro received an annual equity grant of 1,349.82 restricted stock units. The award, made under the Marsh & McLennan Companies Directors Stock Compensation Plan, is valued at a reference price of $159.28 per unit and converts into common stock on a 1-for-1 basis.
Following this grant, Schapiro directly holds 90,445.40 shares of common stock, including the underlying shares from these units. This is a compensation-related award rather than an open-market purchase or sale.
Marsh & McLennan Companies director Anthony Anderson received an annual equity grant of 1,349.82 restricted stock units. The award was made under the Marsh & McLennan Companies Directors Stock Compensation Plan and is classified as a grant or award acquisition, not an open-market purchase.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis, aligning the director’s compensation with future share performance. Following this grant, Anderson holds a total of 17,082.15 units directly, reinforcing his equity stake in the company.
Marsh & McLennan Companies director Deborah C. Hopkins received an annual equity grant under the company’s Directors Stock Compensation Plan. She was awarded 1,349.82 restricted stock units that convert into common stock on a 1-for-1 basis, reflecting a reference price of $159.28 per share. Following this grant, she directly holds 21,414.56 shares-equivalent of common stock. This is a compensation-related award, not an open-market purchase or sale.
Marsh & McLennan Companies director Tamara Ingram received an annual stock award in the form of 1,349.82 restricted stock units under the company’s Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
After this grant, Ingram directly holds 9,086.35 shares-related units, reflecting routine, compensation-based equity rather than an open-market purchase or sale.
Marsh & McLennan Companies director Lloyd M. Yates received an annual stock award of restricted stock units. On June 1, 2026, he was granted 1,349.82 restricted stock units under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis, bringing his directly held equity-related position reported in this filing to 12,390.99 shares on a converted basis. This is a compensation-related equity grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.
Marsh & McLennan Companies director Jan Siegmund received an annual stock award of 1,349.82 restricted stock units on Marsh & McLennan common stock. The units were valued at $159.28 per underlying share and convert into common stock on a 1-for-1 basis.
Following this grant, Siegmund directly holds 2,298.24 restricted stock units linked to Marsh & McLennan common stock. This is a compensation-related award rather than an open-market purchase or sale.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills reported an annual stock award, not an open‑market trade. He received a grant of 1,349 shares of common stock at $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this compensation grant, he holds 5,757.75 shares directly and 47,553 shares indirectly through a trust.
HANWAY H EDWARD reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director H. Edward Hanway received an annual stock award of 1,349 shares of Common Stock. The award was granted on June 1, 2026 under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
After this grant, Hanway directly holds a total of 36,867.7 shares of Marsh & McLennan common stock. This is a compensation-related equity award, not an open‑market purchase or sale.
Hartmann Judith reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Judith Hartmann received an annual stock award of 1,349 shares of Common Stock. The shares were granted on June 1, 2026 at a reported price of $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan.
Following this grant, Hartmann directly holds 4,323 shares of the company’s common stock. This is a compensation-related award rather than an open-market purchase, so it reflects standard director remuneration rather than a trading decision based on the share price.
Marsh & McLennan Companies director Peter Harrison reported compensation-related stock transactions. He received an annual stock award of 1,349 shares of common stock under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
To cover applicable taxes on shares acquired with director fees under the same plan, 103.39 shares of common stock were withheld in a tax-withholding disposition. After these transactions and receipt of cash in lieu of a fractional share, Harrison directly holds 1,349.82 shares of Marsh & McLennan common stock.
BROUSSARD BRUCE D reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Bruce D. Broussard received an annual stock award of 1,349 shares of common stock on June 1, 2026 under the company’s Directors Stock Compensation Plan. The grant was valued at $159.28 per share and increased his direct holdings to 1,425 shares.
Marsh & McLennan Companies director Morton O. Schapiro reported routine equity compensation activity. On May 15, 2026, he received 256.85 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, valued at $160.60 per unit. A separate adjustment of 495.08 restricted stock units reflects dividend equivalents credited under the same plan. Each restricted stock unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis, and Schapiro now holds more than 88,000 restricted stock units directly.
MARSH & MCLENNAN COMPANIES, INC. director Deborah C. Hopkins reported an administrative Form 4 update related to her director stock compensation. On 2026-05-15, 111.82 restricted stock units were credited to her account at a reference price of $160.60 per unit through dividend equivalents.
These restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Hopkins directly holds a total of 20,064.74 restricted stock units under the directors stock compensation plan.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported a routine compensation-related adjustment to her equity holdings. She received 43.11 restricted stock units under the Directors Stock Compensation Plan, credited as dividend equivalents and tied to the company’s common stock on a 1-for-1 basis.
Following this transaction, Ingram holds a total of 7,736.53 restricted stock units directly. The filing does not reflect any open-market purchase or sale of Marsh & McLennan common shares, but rather an administrative update to her stock-based compensation balance.
Lute Jane H reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Jane H. Lute reported routine equity compensation activity. She received 169.29 restricted stock units under the Directors Stock Compensation Plan at a reference price of $160.60 per unit. An additional 41.2 units were credited as dividend equivalents, all convertible into common stock on a 1-for-1 basis.
Marsh & McLennan director Jan Siegmund reported an internal equity adjustment involving 5.29 restricted stock units credited as dividend equivalents under the Directors Stock Compensation Plan. These units convert to common stock on a 1‑for‑1 basis, increasing his restricted stock unit holdings to 948.42.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills received an award of 264 shares of common stock at $160.60 per share as part of his director fees under the company’s Directors Stock Compensation Plan. Following this grant, he holds 4,408.75 shares directly and 47,553 shares indirectly through a trust.
Marsh & McLennan Companies reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received a grant of 14,907 restricted stock units. Each unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028 and May 15, 2029. Following this award, Klisura is reported as directly holding 14,907 restricted stock units tied to common stock.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received a grant of 5,963 restricted stock units as equity compensation. Each unit converts into one share of common stock. These RSUs vest in three equal annual installments on May 15, 2027, 2028 and 2029, leaving him with 5,963 units reported after this grant.
Beswick Paul reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick received a grant of 14,907 restricted stock units. These RSUs represent future rights to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, encouraging longer-term alignment between the executive and shareholders. All 14,907 RSUs are reported as directly owned following this grant.
South Martin reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies’ Chief Client Officer South Martin received a grant of 5,963 restricted stock units. These units represent the right to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis, subject to vesting conditions.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029. This is a compensation-related award rather than an open-market stock purchase or sale, and after this grant Martin holds 5,963 restricted stock units directly.
MCGIVNEY MARK C reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies executive Mark C. McGivney received a grant of 59,627 restricted stock units. These units were awarded as compensation and are convertible into an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028, and 2029, subject to continued service and any plan terms. Following this grant, McGivney holds 59,627 restricted stock units directly, with no open-market buying or selling reported in this filing.
MARSH & MCLENNAN COMPANIES, INC. reported that executive Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 8,945 restricted stock units (RSUs) on Marsh & McLennan common stock as equity-based compensation.
The RSUs convert into common stock on a 1-for-1 basis and are scheduled to vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this award, Studer holds a total of 14,711 RSUs directly. This is a compensation-related grant, not an open-market share purchase or sale.
Marsh & McLennan Companies President and CEO John Q. Doyle received a grant of 89,441 restricted stock units as equity compensation. These units convert into common stock on a 1-for-1 basis and vest in three equal annual installments on May 15, 2027, 2028, and 2029.
Marsh & McLennan Companies reported that Patrick Tomlinson, President and CEO of Mercer, received a grant of 14,907 restricted stock units. These units convert into Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this grant, Tomlinson holds 19,761 restricted stock units directly.
MARSH & MCLENNAN COMPANIES, INC. reported that SVP and Chief People Officer Carmen Fernandez received a grant of 5,963 restricted stock units.
The units convert into common stock on a 1-for-1 basis and vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this grant, she holds 5,963 restricted stock units directly.
Brennan Katherine reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. reported that SVP and General Counsel Katherine Brennan received a grant of 5,963 Restricted Stock Units. Each unit is convertible into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The RSUs vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, tying the award to multi-year service and performance with the company.
Marsh & McLennan Companies reported that Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 5,766 restricted stock units on common stock as equity compensation. The units were granted at no cash cost and convert into common stock on a 1-for-1 basis.
These restricted stock units are scheduled to vest on April 15, 2029. Following this grant, Studer holds 5,766 restricted stock units directly under this award, reflecting a routine long-term incentive grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported the vesting and conversion of restricted stock units into common stock. On March 15, 2026, 1,228 RSUs converted into 1,228 shares of common stock on a 1-for-1 basis. Of these, 627 shares were withheld by the company at $172.15 per share to cover applicable taxes, leaving Tomlinson with additional net shares and 4,256 common shares held directly after the transactions. No remaining derivative positions are shown in this filing, indicating a routine compensation-related vesting with tax withholding rather than an open-market trade.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported an open-market sale of common stock. On March 11, 2026, he sold 2,362 shares at an average price of $173.6101 per share. After the sale, he directly held 7,978 shares, with an additional 1,819.885 shares held indirectly through the MMC 401(k) Savings & Investment Plan.
Marsh & McLennan Companies, Inc. President and CEO John Q. Doyle exercised stock options and sold shares on March 4, 2026. He exercised options for 16,655 Stock Options (Right to Buy) at $0.0000 per share, leaving 49,968 options held directly. He then sold 16,655 shares of Common Stock at an average price of $183.3000 per share in an open‑market transaction under a previously adopted Rule 10b5‑1 trading plan, and held 116,811.0205 common shares directly afterward.
Marsh & McLennan Companies executive Nicholas Mark Studer reported an open-market sale of 3,837 shares of common stock. The shares were sold on March 3, 2026 at an average price of $184.0299 per share to satisfy tax withholding obligations. After this transaction, he directly holds 32,536 shares of the company.
Marsh & McLennan Companies SVP and Chief Information Officer Paul Beswick reported routine equity compensation activity. On vesting, 6,970 restricted stock units converted into an equal number of common shares on a 1-for-1 basis. Of these, 3,403 shares were withheld by the company to cover applicable taxes, leaving Beswick with 17,089 shares of common stock held directly.
Marsh & McLennan Companies SVP and General Counsel Katherine Brennan reported the vesting of 6,970 restricted stock units into common stock. The units, which relate to performance stock units granted on February 23, 2023 for the 2023-2025 performance period, converted to common stock on a 1-for-1 basis on February 28, 2026.
Of these 6,970 shares, 3,855 common shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share to cover applicable taxes, reflecting a tax-withholding disposition rather than an open-market sale. Following these transactions, Brennan directly owns 7,330 shares of Marsh & McLennan Companies common stock.
Marsh & McLennan Companies President and CEO John Q. Doyle reported equity compensation activity involving restricted stock units and common stock. On February 28, 2026, 59,510 restricted stock units vested and converted into an equal number of Marsh & McLennan common shares on a 1-for-1 basis. To cover applicable taxes on this vesting, 30,380 common shares were withheld by the company at a price of $186.74 per share. After these transactions, Doyle directly owned 116,811.0205 shares of common stock.
Marsh & McLennan Companies executive Carmen Fernandez, SVP and Chief People Officer, reported equity award activity tied to previously granted performance stock units. On February 28, 2026, 6,970 restricted stock units vested and converted into common shares on a 1-for-1 basis. Of these, 3,855 shares of common stock were withheld by the company to cover applicable taxes at a price of $186.74 per share, a tax-withholding disposition rather than an open-market sale. Following these transactions, Fernandez directly owned 12,995 shares of common stock, and indirectly held 282.917 shares through the Marsh & McLennan Companies 401(k) Savings & Investment Plan, based on the plan statement as of February 28, 2026.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported equity award activity involving restricted stock units and common stock. On February 28, 2026, 4,826 restricted stock units converted into common shares on a 1-for-1 basis, reflecting vesting of performance stock units granted on February 23, 2023 for the 2023–2025 performance period.
Of these shares, 2,464 common shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share to cover applicable taxes. After these transactions, Jones directly held 10,340 common shares and 140.602 restricted stock units under the Supplemental Savings & Investment Plan.
In addition, 1,819.885 common shares were held indirectly through the Marsh & McLennan Companies 401(k) Savings & Investment Plan, with the plan custodian acquiring shares at prevailing market prices as of February 28, 2026.
Marsh & McLennan Companies executive Dean Michael Klisura reported equity compensation activity involving restricted stock units and common shares. On February 28, 2026, 9,383 restricted stock units vested and converted into an equal number of common shares on a 1‑for‑1 basis. Of these, 5,189 shares were withheld by the company at a price of $186.74 per share to cover taxes, leaving the remainder added to his directly held common stock, which totaled 25,129.48 shares after the tax withholding. He also reported 1,679.724 restricted stock units under the Supplemental Savings & Investment Plan, reflecting additional units acquired by the plan custodian at prevailing market prices as of that date.
Marsh & McLennan Companies Chief Financial Officer Mark C. McGivney reported the vesting and distribution of 17,961 restricted stock units that convert into common stock on a 1-for-1 basis. These units relate to performance stock units granted on February 23, 2023 for the 2023-2025 performance period.
Of the 17,961 resulting common shares, 9,170 shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share to cover applicable taxes. Following these transactions, McGivney directly holds 42,469 shares of common stock.
Marsh & McLennan Companies Vice President and Controller Stacy Mills had 2,723 restricted stock units vest and convert into common shares on a 1-for-1 basis. Of these, 1,277 shares were withheld by the company at $186.74 per share to cover taxes. Mills now directly holds 4,151.098 common shares and 2,916 restricted stock units.
Marsh & McLennan Companies President & CEO of Marsh Risk, South Martin, reported equity compensation activity. On the transaction date, 14,476 restricted stock units vested and converted into the same number of common shares on a 1-for-1 basis. Of these, 8,006 shares were withheld by the company at a price of $186.74 per share to cover applicable taxes, classified as a tax-withholding disposition rather than an open-market sale. The vested units relate to performance stock units granted on February 23, 2023 for the 2023-2025 performance period. Following these transactions, Martin directly held 23,650.539 common shares, which includes 118.022 shares acquired under the employee stock purchase plan for several quarters in 2025.
Marsh & McLennan Companies, Inc. executive Nicholas Mark Studer reported the vesting of restricted stock units that converted into common stock. On February 28, 2026, 8,044 restricted stock units tied to performance for 2023–2025 were exercised on a 1‑for‑1 basis into 8,044 shares of common stock at no cash exercise price. Following this conversion, Studer directly owned 36,373 shares of Marsh & McLennan common stock.
Marsh & McLennan Companies President and Mercer CEO Patrick Tomlinson reported the vesting of restricted stock units and related tax withholding. On the transaction date, 2,219 restricted stock units vested and converted into an equal number of common shares on a 1-for-1 basis. To cover applicable taxes, 1,134 of these shares were withheld by Marsh & McLennan Companies at a price of $186.74 per share, leaving the remainder delivered to Tomlinson. After these transactions, he directly owned 3,655 shares of common stock and 6,082 restricted stock units.
Marsh & McLennan Companies Chief Financial Officer receives new equity awards. On February 24, 2026, Mark C. McGivney was granted stock options for 44,743 shares at no cost and 17,961 restricted stock units, both held directly.
The options were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030. Both the options and restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. The restricted stock units relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick acquired equity awards on February 24, 2026. He received 22,372 stock options that vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
Beswick also acquired 6,970 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both the options and units convert into common stock on a 1‑for‑1 basis.
Marsh & McLennan Companies senior vice president and general counsel Katherine Brennan reported equity awards on common stock. She received stock options for 22,372 shares, which were granted on February 24, 2026 and vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
She was also granted 6,970 restricted stock units that convert into common stock on a 1-for-1 basis. These RSUs relate to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies reported an equity award for SVP and Chief People Officer Carmen Fernandez. She acquired stock options for 18,643 shares at no cost, vesting in four equal annual installments from February 24, 2027 through February 24, 2030. She also acquired 6,970 restricted stock units that convert into common stock on a 1-for-1 basis and relate to performance stock units originally granted for the 2023–2025 performance period, with the performance factor determined on February 24, 2026.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received new equity awards. On February 24, 2026 he was granted 15,536 stock options, which vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
He also acquired 4,826 restricted stock units tied to performance stock units originally granted on February 23, 2023 for the 2023–2025 performance period. Both instruments convert into Marsh & McLennan common stock on a 1‑for‑1 basis.